Invasive diagnostic testing used for chromosomal, Mendelian, metabolic, and congenital infective diseases is represented nowadays by three main procedures: chorionic villous sampling (CVS), amniocentesis, and fetal blood sampling (FBS). The last technique due to deoxyribonucleic acid and polymerase chain reaction (DNA-PCR) analysis is ever less employed. All these techniques imply continuous ultrasound monitoring of the needle insertion in the uterus. Nondirective genetic counseling possibly before pregnancy is mandatory to explain the indications, the procedure itself, the fetal risks, the possibility for misdiagnosis and the time for receiving the results.
INTRODUCTION
The most common invasive prenatal diagnosis to avoid birth defects can be performed before conception by polar body biopsy, before implantation by blastomere or blastocyst biopsy on more diffused in pregnancy by CVS, by amniocentesis or by FBS, by cordocentesis or intrahepatic vein puncture (Fig. 1) . 1 The first step in prenatal invasive procedures is nondirective genetic counseling in order to inform patients about their reproductive risks and genetic disease investigating, the familiarity of screening, diagnosis, prognosis and treatment, the risks related to the invasive procedures, their diagnostic limitations and the time for receiving the diagnosis, the modes of the procedures and all the options, including termination of pregnancy and fetal therapy. 
INVASIVE DIAGNOSTIC TESTING

Chorionic Villous Sampling
The most commonly used is transabdominal CVS (TA-CVS) with a 20-gauge spinal needle introduced by free-hand technique and under continuous ultrasound monitoring following the 10th gestational week. 2 Transabdominal-CVS is more popular than the transcervical route because it can be used at any time of gestation, implies a lower risk of infections, it is easier, quicker, less painful, suggests better privacy, and is better accepted by women. 3 The fetal risk, if the operator is expert in the procedure, is low (1:500-1:800) and the indications are fetal karyotype, Mendelian, and metabolic diseases. 4 The most common use is following first-trimester combined screening 5, 6 using the ultrasound fetal NT measurement and biochemistry markers, such as PAPP-A and free beta-hCG, and after a positive cell-free DNA screening in maternal circulating blood. 7 The analysis accuracy for karyotype is higher and for Mendelian diseases such as thalassemia 8 and metabolic diseases, it is the technique of choice. 
Amniocentesis
It is the most common and widespread technique performed following 15 weeks of pregnancy employing the free-hand technique and a 22-gauge spinal needle under continuous ultrasound monitoring.
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DSJUOG
The fetal loss risk is similar to TA-CVS (1:500-1:800) 11 and is used for karyotype analysis following first-trimester combined screening and triple/quadruple secondtrimester biochemistry screening. It is also the technique of choice for congenital infection diseases and for alfafetoprotein the diagnostic accuracy is very high.
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Fetal Blood Sampling
The most common are cordocentesis by free-hand technique and spinal 20-or 22-gauge needle introduced in the umbilical cord under continuous ultrasound monitoring. 10 Meanwhile, the intrahepatic vein puncture is less used. 11 The fetal risk is 1 to 2% in expert hands. The indications and the use of FBS are decreasing because of the wider use of CVS and amniocentesis for karyotype and for DNA analysis.
12
Transabdominal CVS and Amniocentesis
Transabdominal CVS and amniocentesis both have the same low percentage of fetal risk and high accuracy of analysis. The CVS is preferred for early diagnosis, for Mendelian and metabolic diseases because the DNA extracted by the chorion is more accurate for the analysis. 8 Also CVS is more appropriate in case of high genetic risk, and following first-trimester positive combined test 13 and cell-free DNA positives. 7 The TA-CVS is also the technique of choice in multiple pregnancies in case of embryo reduction or selective feticide. 14 Both techniques are also used following ultrasound findings of fetal malformations.
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Preimplantation Genetic Diagnosis
When couples at high genetic risk prefer not having a child affected by genetic diseases and avoiding the possible termination of pregnancy, then PGD can be applied. 16 The most used technique is the analysis of a single or more cells from the embryo and molecular analysis by DNA polymerase chain reaction or fluorescent in situ hybridization. The acceptance of PGD is very high, mostly for women who have already had a termination of pregnancy following a previous prenatal diagnosis. 17 The PGD is expensive and implies the use of assisted reproduction techniques, such as in vitro fertilization and intracytoplasmic sperm injection.
INVASIVE PRENATAL TECHNIQUES AND SCREENING
The introduction of first-trimester combined screening and cell-free DNA NIPS caused an important decrease of the invasive procedures because women are reassured in case of negative or low-risk screening. 18 All prenatal centers are witnessing a reduction of 30 to 70% of prenatal invasive procedures in the last 3 to 5 years and this concerns mainly amniocentesis. In our center, the decrease is about 40% and it is regarding mostly amniocentesis; in the meanwhile, TA-CVS is increasing (Graph 1). The reduction of invasive prenatal procedures brings each year many young fellows from all over the world (Graph 2) to our center who wish to be tutored in TA-CVS and other invasive procedures. 19 At the end of their training, they receive the Ian Donald School Diploma in invasive prenatal procedures (Fig. 2) .
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CONCLUSION
Nowadays, invasive prenatal procedures are still in use and are essential in maternal-fetal medicine centers. The combination between ultrasound, molecular biology, and the experience of the operator make the planning of a pregnancy more conscientious and acceptable as well as reduces the birth defects.
